121 related articles for article (PubMed ID: 12099513)
1. Interleukin-2-mediated survival and proliferative signals are uncoupled in T lymphocytes that fail to divide after activation.
Kreisel D; Sankaran D; Wells AD; Turka LA
Am J Transplant; 2002 Feb; 2(2):120-8. PubMed ID: 12099513
[TBL] [Abstract][Full Text] [Related]
2. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
Inaba H; Geiger TL
Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
[TBL] [Abstract][Full Text] [Related]
3. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
[TBL] [Abstract][Full Text] [Related]
4. Prevention of interleukin-2 withdrawal-induced apoptosis in lymphocytes retrovirally cotransduced with genes encoding an antitumor T-cell receptor and an antiapoptotic protein.
Kalbasi A; Shrimali RK; Chinnasamy D; Rosenberg SA
J Immunother; 2010 Sep; 33(7):672-83. PubMed ID: 20664359
[TBL] [Abstract][Full Text] [Related]
5. The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.
Walsh PT; O'Connor R
Eur J Immunol; 2000 Apr; 30(4):1010-8. PubMed ID: 10760788
[TBL] [Abstract][Full Text] [Related]
6. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response.
Radvanyi LG; Shi Y; Vaziri H; Sharma A; Dhala R; Mills GB; Miller RG
J Immunol; 1996 Mar; 156(5):1788-98. PubMed ID: 8596028
[TBL] [Abstract][Full Text] [Related]
7. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.
Tai XG; Toyooka K; Yashiro Y; Abe R; Park CS; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
J Immunol; 1997 Oct; 159(8):3799-807. PubMed ID: 9378967
[TBL] [Abstract][Full Text] [Related]
8. Death by neglect as a deletional mechanism of peripheral tolerance.
Bertolino P; Trescol-Biémont MC; Thomas J; Fazekas de St Groth B; Pihlgren M; Marvel J; Rabourdin-Combe C
Int Immunol; 1999 Aug; 11(8):1225-38. PubMed ID: 10421780
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.
Manicassamy S; Gupta S; Huang Z; Sun Z
J Immunol; 2006 Jun; 176(11):6709-16. PubMed ID: 16709830
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
[TBL] [Abstract][Full Text] [Related]
11. T cell effector function and anergy avoidance are quantitatively linked to cell division.
Wells AD; Walsh MC; Sankaran D; Turka LA
J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
[TBL] [Abstract][Full Text] [Related]
12. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
Kim EY; Teh HS
J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.
Burr JS; Savage ND; Messah GE; Kimzey SL; Shaw AS; Arch RH; Green JM
J Immunol; 2001 May; 166(9):5331-5. PubMed ID: 11313368
[TBL] [Abstract][Full Text] [Related]
14. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability.
Rathmell JC; Vander Heiden MG; Harris MH; Frauwirth KA; Thompson CB
Mol Cell; 2000 Sep; 6(3):683-92. PubMed ID: 11030347
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-X(L) restores cell survival, but not proliferation off effector differentiation, in CD28-deficient T lymphocytes.
Dahl AM; Klein C; Andres PG; London CA; Lodge MP; Mulligan RC; Abbas AK
J Exp Med; 2000 Jun; 191(12):2031-8. PubMed ID: 10859328
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
Chetoui N; Boisvert M; Gendron S; Aoudjit F
Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
Akbar AN; Borthwick NJ; Wickremasinghe RG; Panayoitidis P; Pilling D; Bofill M; Krajewski S; Reed JC; Salmon M
Eur J Immunol; 1996 Feb; 26(2):294-9. PubMed ID: 8617294
[TBL] [Abstract][Full Text] [Related]
18. "In vivo" activated splenic T cells are refractory to interleukin 2 growth "in vitro".
Bandeira A; Larsson EL; Forni L; Pereira P; Coutinho A
Eur J Immunol; 1987 Jul; 17(7):901-8. PubMed ID: 3111860
[TBL] [Abstract][Full Text] [Related]
19. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade.
Ostiguy V; Allard EL; Marquis M; Leignadier J; Labrecque N
J Leukoc Biol; 2007 Sep; 82(3):645-56. PubMed ID: 17554014
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of IL-2 and IL-15 on the death and survival of activated TCR gamma delta+ intestinal intraepithelial lymphocytes.
Chu CL; Chen SS; Wu TS; Kuo SC; Liao NS
J Immunol; 1999 Feb; 162(4):1896-903. PubMed ID: 9973456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
